It also stimulates collagen production for stronger, more elastic skin
2021RC4056) and Key Program of Ministry of Industry and Information Technology of China (CEIEC-2022-ZM02-0219) for financial support
Jiang, Y., Liao, L., Yang, F., Zeng, X., & Zhang, W
The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release
All of these things make the price high